---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-014972"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T09:12:02.405290+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Indaptus raises $2.3M via convertible notes and warrants; up to $5M total

## Summary
- $2.3M aggregate principal of 6% convertible promissory notes; mature July 28, 2026.
- Conversion at 80% of 5-day VWAP, max $0.40; warrants for 200% of conversion shares after approval.
- Net proceeds for R&D, Phase 1b/2 trial funding, and general working capital.
- Offering may increase to $5M; Paulson Investment Company is exclusive placement agent with 12% fee.
- Company must hold special meeting for stockholder approval; note conversion tied to reverse split or 1 year.

## SEC filing metadata
- accession: 0001641172-25-014972
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000164117225014972/0001641172-25-014972-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000164117225014972/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-014972
- JSON: https://secwatch.observer/filing/0001641172-25-014972.json
- Plain text: https://secwatch.observer/filing/0001641172-25-014972.txt

## Key facts
- Debt Financings
  Indaptus Therapeutics, Inc. incurred convertible notes of aggregate principal amount of $2.3 million with certain accredited investors at 6% per year maturing July 28, 2026.
  - Instrument: convertible notes
  - Principal: aggregate principal amount of $2.3 million
  - Counterparty: certain accredited investors
  - Rate: 6% per year
  - Maturity: July 28, 2026
  - Event: incurrence
  source text: the offering in a private placement of convertible promissory notes in the aggregate principal amount of $2.3 million (the "Notes") and warrants (the "Warrants") to purchase shares of common stock, par value $0.01 per share ("Common Stock"). The closing of private placement occurred on June 12, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000164117225014972/0001641172-25-014972-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.